New positive results from GSK’s TB vaccine in HIV negative patients

GSK announce promising results from a study conducted in partnership with non-profit scientific research organisation IAVI, that is investigating the efficacy of the company’s tuberculosis (TB) vaccine in HIV-negative adults with latent TB infection. The study was conducted across 11 sites throughout Kenya, South Africa and Zambia, which are all TB-endemic regions, and enrolled over

Continue Reading

BMS Foundation Announces Collaboration with WHO Stop TB Department

The Bristol-Myers Squibb Foundation yesterday announced a partnership with the World Health Organization’s (WHO) Stop TB Department for a two-year pilot initiative to strengthen community based prevention, care and control of tuberculosis (TB) including co-infection with HIV in South Africa, Tanzania, Kenya, Ethiopia and Democratic Republic of the Congo. These countries represented more than 13%

Continue Reading